President Obama said his first priority in the Malaysia Airlines passenger jet crash is to find out if Americans were on board. CNBC's Eamon Javers outlines how Obama spent his day.» Read More
The law known as Obamacare, President Barack Obama's signature domestic policy achievement, provides federally subsidized private coverage through new online insurance marketplaces and an expansion of Medicaid in 26 states and Washington, D.C..
FDA regulators approved the drug for daily, round-the-clock pain that does not respond to other medications. The FDA notes that Targiniq can still be abused by simply swallowing the tablets, the most frequent method of painkiller abuse. The FDA has been under intense public pressure to combat the national epidemic of prescription opioid abuse.
WASHINGTON— NASA doesn't have enough money to get its new, $12 billion rocket system off the ground by the end of 2017 as planned, federal auditors say. The Government Accountability Office issued a report Wednesday saying NASA's Space Launch System is at "high risk of missing" its planned December 2017 initial test flight.
WASHINGTON— Six years ago the Social Security Administration embarked on an aggressive plan to replace outdated computer systems overwhelmed by a growing flood of disability claims. In 2008, Social Security said the project was about two to three years from completion.
WASHINGTON— Potentially tens of thousands of students awarded a Pell Grant or other need-based federal aid for the coming school year could find it taken away because of a mistake in filling out the form. Fewer than 200,000 applicants have been declared eligible when they are not, the Education Department said.
WASHINGTON— Figures on government spending and debt.
WASHINGTON— The Food and Drug Administration warned doctors Wednesday not to use compounded drugs from a Texas specialty pharmacy due to potential risks of contamination. The agency says FDA inspectors recently uncovered unsanitary conditions at Unique Pharmaceuticals' plant in Temple, Texas.
But the downing last week of a Malaysia Airlines plane over eastern Ukraine, killing 298 people, jolted the EU into action. Foreign ministers for the first time this week singled out sectors of the Russian economy that the EU might target with sanctions in protest at Moscow's actions in eastern Ukraine.
WASHINGTON, July 23- A top official will leave the U.S. Commodity Futures Trading Commission to become the head of a banking group 10 days later in a spin through the revolving regulator-to-lobby-group door that is striking even by Washington standards.
July 23- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer. The FDA approved the use of Zydelig in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.
WASHINGTON— The Senate agreed Wednesday on an $11 billion measure to temporarily fix a multibillion-dollar shortfall in federal highway and transit programs, setting up a vote next week on several alternatives.
WASHINGTON— Out of a seemingly hollow recovery from the Great Recession, a more durable if still slow-growing U.S. economy has emerged. That conclusion, one held by a growing number of economists, might surprise many people. After all, in the five years since the recession officially ended, Americans' pay has basically stagnated.
"EPA goes beyond the plain reading of Clean Air Act Section 111 directing states to achieve questionable emission reduction targets from a limited menu of economically damaging and legally questionable' options'," said Senator David Vitter of Louisiana, the committee's top Republican.
HAMBURG/ FRANKFURT, July 23- Hamburg has told Uber, a U.S. car service whose smartphone app summons rides at the touch of a button, to stop operating in the German city, adding to resistance the company has faced globally from local regulators and taxi drivers.
WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.
WASHINGTON— At 91, Bob Dole won't take no for an answer. Veterans groups, organizations for the disabled and a handful of the Senate's strongest proponents joined Dole in stepping up the pressure for a Senate vote. Dole, who celebrated his 91st birthday on Tuesday, sat through the Capitol Hill news conference and spoke forcefully about the treaty.
July 23- The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday. The FDA approved it for use in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.
WASHINGTON— U.S. economic growth this year will likely be at the weakest pace since the Great Recession ended, the International Monetary Fund said, mostly because of a sharp, weather-related contraction in the first quarter. That's below last year's 1.9 percent pace and would be the slowest annual rate since the recession ended in June 2009.
WASHINGTON— The chairman of the Senate Veterans' Affairs Committee said Wednesday there is still time for Congress to approve a landmark bill to improve health care services for veterans, despite deep disagreement over how much the changes will cost and how they should be paid for.
WASHINGTON— The Senate voted Wednesday to advance an election-year bill limiting tax breaks for U.S. companies that move operations overseas. The Senate voted 93-7 to begin debating the bill, which would prevent companies from deducting expenses related to moving operations to a foreign country.